Pan Hammarström Lab

We focus on two main areas of research: Primary immunodeficiency and B cell malignancy

Pan Hammarström group picture 2024

We focus on two main areas of research; Primary immunodeficiency and B cell malignancy. 

These are our four projects:

  • Regulation of immunoglobulin class switch recombination in human B cells
  • Induced pluripotent stems cells a platform for personalized diagnosis and therapy in patients with primary immunodeficiency
  • Discovery of therapeutic targets in B cell lymphoma by next generation sequencing
  • Antibody therapy against COVID-19

Research techniques

  • DNA sequencing, including whole exome and whole genome sequencing
  • Gene expression analysis including real time PCR and RNAseq/transcriptome analysis
  • B and T cell functional assays
  • Generating iPSCs
  • Gene editing using the CRISPR/Cas9 system

Looking for a postdoc position?

Postdoc positions on B cell development, immunogenetics, COVID19 and cancer genetics available.

For details contact: Prof. Pan-Hammarström

News archive

Keywords:
Basic Cancer Research Immunology in the Medical Area Medical Biotechnology (Focus on Cell Biology (incl. Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy) Medical Genetics and Genomics
Content reviewer:
Sara Lidman
29-04-2024